This Article Figures Only Full Text Full Text (PDF) View Related Cardiosource Journal Scan Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Daemen, J. Search for Related Content PubMed PubMed Citation Articles by Daemen, J. Related Collections Related Article

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Multivessel Coronary Revascularization in Patients With and Without Diabetes Mellitus

3-Year Follow-Up of the ARTS-II (Arterial Revascularization Therapies Study–Part II) Trial

Joost Daemen, MD^_*, Karl Heinz Kuck, MD, Carlos Macaya, MD, Victor LeGrand, MD, Maarten Vrolix, MD^||, Didier Carrie, MD^¶, Imad Sheiban, MD^#, Maarten Jan Suttorp, MD^_**, Pascal Vranckx, MD, Tessa Rademaker, MSc, Dick Goedhart, PhD, Monique Schuijer, PhD, Kristel Wittebols, MSc, Nathalie Macours, PhD, Hans Peter Stoll, MD, Patrick W. Serruys, MD, PhD^_*,_* on behalf of the ARTS-II Investigators

^_* Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands
Hospital St. Georg, Hamburg, Germany
Hospital Clinico San Carlos, Madrid, Spain
CHU Sart Tilman, Liege, Belgium
^|| Ziekenhuis Oost Limburg, Genk, Belgium
^¶ CHY Popital de Rangueil, Toulouse, France
^# Azienda Ospedaliera San Giovanni Batista, Torino, Italy
^_** Sint Antonius Hospital Nieuwegein, Nieuwegein, the Netherlands
Hospital Virga Jesse, Hasselt, Belgium
Cardialysis B.V., Rotterdam, the Netherlands
Cordis Clinical Research Europe, Waterloo, Belgium

Manuscript received June 16, 2008; revised manuscript received August 14, 2008, accepted September 2, 2008.

^_* Reprint requests and correspondence: Prof. Patrick W. Serruys, Thoraxcenter, Ba-583, s-Gravendijkwal 230, 3015 CE Rotterdam, the Netherlands (Email: p.w.j.c.serruys{at}erasmusmc.nl).

Objectives: The purpose of this study was to assess the 3-year outcome of coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) in patients who had multivessel coronary artery disease with and without diabetes mellitus.

Background: The optimal method of revascularization in diabetic patients remains in dispute.

Methods: The ARTS-II (Arterial Revascularization Therapies Study–Part II) trial is a single-arm study (n = 607) that included 159 diabetic patients treated with SES whose 3-year clinical outcome was compared with that of the historical diabetic and nondiabetic arms of the randomized ARTS-I trial (n = 1,205, including 96 diabetic patients in the CABG arm and 112 in the PCI arm).

Results: At 3 years, among nondiabetic patients, the incidence of the primary composite of death, CVA, myocardial infarction (MI), and repeat revascularization (major adverse cardiac and cerebrovascular events [MACCE]), was significantly lower in ARTS-II than in ARTS-I PCI (adjusted odds ratio [OR]: 0.41; 95% confidence interval [CI]: 0.26 to 0.64) and similar to ARTS-I CABG. The ARTS-II patients were at significantly lower risk for death, CVA, and MI as compared with both the ARTS-I PCI (adjusted OR: 0.55; 95% CI: 0.34 to 0.91) and ARTS-I CABG patients (adjusted OR: 0.56; 95% CI: 0.35 to 0.92). Among diabetic patients, the incidence of MACCE in ARTS-II was similar to that of both PCI and CABG in ARTS-I. Conversely, the incidence of death, CVA, and MI was significantly lower in ARTS-II than in ARTS-I PCI (adjusted OR: 0.67; 95% CI: 0.27 to 1.65) and was similar to that of ARTS-I CABG.

Conclusions: At 3 years, PCI using SES for patients with multivessel coronary artery disease seems to be safer and more efficacious than PCI using bare-metal stents, irrespective of the diabetic status of the patient. Hence, PCI using SES appears to be a valuable alternative to CABG for both diabetic and nondiabetic patients.

Key Words: coronary stents • sirolimus-eluting stent • diabetes • all-comers • coronary artery bypass graft surgery

Abbreviations and Acronyms   BMS = bare-metal stent(s)   CABG = coronary artery bypass graft surgery   CI = confidence interval   CK-MB = creatine kinase-myocardial band   CVA = cerebrovascular accident   DES = drug-eluting stent(s)   MACCE = major adverse cardiac and cerebrovascular event(s)   MI = myocardial infarction   OR = odds ratio   PCI = percutaneous coronary intervention   SES = sirolimus-eluting stent(s)

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A32. [Full Text] [PDF]

This article has been cited by other articles:

				M. Y. Emmert, B. Seifert, M. Wilhelm, J. Grunenfelder, V. Falk, and S. P. Salzberg Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1499 - 1506. [Abstract] [Full Text] [PDF]

				M. Y. Emmert, S. P. Salzberg, B. Seifert, H. Rodriguez, A. Plass, S. P. Hoerstrup, J. Grunenfelder, and V. Falk Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease? Eur J Cardiothorac Surg, July 1, 2011; 40(1): 233 - 239. [Abstract] [Full Text] [PDF]

				Y. Onuma, J. J. Wykrzykowska, S. Garg, P. Vranckx, P. W. Serruys, and ARTS I and II Investigators 5-Year Follow-Up of Coronary Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease: Insights From ARTS (Arterial Revascularization Therapy Study)-II and ARTS-I Trials J. Am. Coll. Cardiol. Intv., March 1, 2011; 4(3): 317 - 323. [Abstract] [Full Text] [PDF]

				K.-H. Mak The Continuing Diabetic Drug-Eluting Stents Saga: From Very-Late Stent Thrombosis to Very-Late Late Loss J. Am. Coll. Cardiol. Intv., March 1, 2011; 4(3): 324 - 326. [Full Text] [PDF]

				D.-W. Park, Y.-H. Kim, H.-G. Song, J.-M. Ahn, J. Oh, W.-J. Kim, J.-Y. Lee, S.-J. Kang, S.-W. Lee, C.-W. Lee, et al. Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization: 5-Year Outcomes From the Asan Medical Center-Multivessel Revascularization Registry J. Am. Coll. Cardiol., January 11, 2011; 57(2): 128 - 137. [Abstract] [Full Text] [PDF]

				H. L. Dauerman Percutaneous Coronary Intervention, Diabetes Mellitus, and Death J. Am. Coll. Cardiol., March 16, 2010; 55(11): 1076 - 1079. [Full Text] [PDF]

				A. P. Banning, S. Westaby, M.-C. Morice, A. P. Kappetein, F. W. Mohr, S. Berti, M. Glauber, M. A. Kellett, R. S. Kramer, K. Leadley, et al. Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease: Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents J. Am. Coll. Cardiol., March 16, 2010; 55(11): 1067 - 1075. [Abstract] [Full Text] [PDF]

				P. W. Serruys, Y. Onuma, S. Garg, P. Vranckx, B. De Bruyne, M.-C. Morice, A. Colombo, C. Macaya, G. Richardt, J. Fajadet, et al. 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions J. Am. Coll. Cardiol., March 16, 2010; 55(11): 1093 - 1101. [Abstract] [Full Text] [PDF]

				A. Kapur, R. J. Hall, I. S. Malik, A. C. Qureshi, J. Butts, M. de Belder, A. Baumbach, G. Angelini, A. de Belder, K. G. Oldroyd, et al. Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients: 1-Year Results of the CARDia (Coronary Artery Revascularization in Diabetes) Trial J. Am. Coll. Cardiol., February 2, 2010; 55(5): 432 - 440. [Abstract] [Full Text] [PDF]

				W. M. Wolf, H. A. Vlachos, O. C. Marroquin, J. S. Lee, C. Smith, W. D. Anderson, J. T. Schindler, E. M. Holper, J. D. Abbott, D. O. Williams, et al. Paclitaxel-Eluting Versus Sirolimus-Eluting Stents in Diabetes Mellitus: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry Circ Cardiovasc Interv, February 1, 2010; 3(1): 42 - 49. [Abstract] [Full Text] [PDF]

				S. Garg, J. J. Wykrzykowska, and P. W. Serruys Chapter 14 Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery Oxford Textbook of Interventional Cardiology, January 1, 2010; 1(1): med-9780199569083-chapter - med-9780199569083-chapter. [Abstract] [Full Text]

				A. Kapur and A. Qureshi Chapter 21 Revascularization in diabetes mellitus Oxford Textbook of Interventional Cardiology, January 1, 2010; 1(1): med-9780199569083-chapter - med-9780199569083-chapter. [Abstract] [Full Text]

				U. Benedetto, G. Melina, E. Angeloni, S. Refice, A. Roscitano, B. Fiorani, G. D. Di Nucci, and R. Sinatra Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients Eur J Cardiothorac Surg, October 1, 2009; 36(4): 611 - 615. [Abstract] [Full Text] [PDF]

				W. B. Halbersma, S. C. Arrigoni, G. Mecozzi, J. G. Grandjean, A. P. Kappetein, J. van der Palen, F. Zijlstra, and M. A. Mariani Four-Year Outcome of OPCAB No-Touch With Total Arterial Y-Graft: Making the Best Treatment a Daily Practice Ann. Thorac. Surg., September 1, 2009; 88(3): 796 - 801. [Abstract] [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]

				Drug-Eluting Stents vs. Coronary Artery Bypass Grafts in Patients with Diabetes Journal Watch Cardiology, December 24, 2008; 2008(1224): 3 - 3. [Full Text]